Lonza Launches Engine Equipment Portfolio

Lonza has launched the Lonza Engine technical service platform that includes the equipment portfolio of the legacy Capsugel and Micromacinazione companies. The new offering is designed to address customer needs throughout the entire small molecule drug development process.

The Lonza Engine equipment portfolio has been created to support bioavailability enhancement, encapsulation and early-phase clinical development technologies. It offers machines including micronization, capsule filling and sealing, and powder micro-dosing equipment.

"Lonza offers a powerful range of world-class industrial equipment that has earned the trust of our customers, who can rely on our proven technology: we know it works because we use it first," said Christian Dowdeswell, vice president and head of BU Dosage Forms & Delivery Systems, Lonza Pharma & Biotech. "Above all, our equipment is backed by a global network of business and technical support services designed to help customers to get the most out of their production process."

The Xcelodose powder micro-dosing system within the portfolio provides consistent dose accuracy by precise filling of capsules without excipients or bulking agents. The capsule filling and sealing (CFS) equipment supports lipid-based formulations to improve the bioavailability of poorly soluble compounds. In addition, thanks to the micronization equipment, the desired particle size distribution of the drug substance can be reached in order to improve the drug product performance.

The Lonza Engine platform is backed by Lonza’s technical service that includes basic technical training, advanced seminars, and components ordering support.

The new offering expands Lonza’s equipment portfolio for capsule filling, and now provides solutions for the entire drug product development process.

"The new equipment portfolio complements our offerings for the pharma and consumer health and nutrition industries and supports our goal to serve markets along the Healthcare Continuum," added Fabio Invernizzi, vice president of Global Sales, Capsule Delivery Solutions, Lonza Pharma & Biotech.

Register as Visitor to CPhI China 2019 NOW!

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com